FI64942C - Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav - Google Patents

Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav Download PDF

Info

Publication number
FI64942C
FI64942C FI772557A FI772557A FI64942C FI 64942 C FI64942 C FI 64942C FI 772557 A FI772557 A FI 772557A FI 772557 A FI772557 A FI 772557A FI 64942 C FI64942 C FI 64942C
Authority
FI
Finland
Prior art keywords
compound
formula
dihydro
acid
therapeutic
Prior art date
Application number
FI772557A
Other languages
English (en)
Finnish (fi)
Other versions
FI772557A (fi
FI64942B (fi
Inventor
Peter Stuetz
Paul Stadler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128676A external-priority patent/CH623591A5/de
Priority claimed from CH1128776A external-priority patent/CH623592A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI772557A publication Critical patent/FI772557A/fi
Publication of FI64942B publication Critical patent/FI64942B/fi
Application granted granted Critical
Publication of FI64942C publication Critical patent/FI64942C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI772557A 1976-09-06 1977-08-29 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav FI64942C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128676 1976-09-06
CH1128776 1976-09-06

Publications (3)

Publication Number Publication Date
FI772557A FI772557A (fi) 1978-03-07
FI64942B FI64942B (fi) 1983-10-31
FI64942C true FI64942C (fi) 1984-02-10

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772557A FI64942C (fi) 1976-09-06 1977-08-29 Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav

Country Status (15)

Country Link
JP (1) JPS5331698A (da)
AU (1) AU512027B2 (da)
CA (1) CA1105007A (da)
DE (1) DE2738730A1 (da)
DK (1) DK147390C (da)
ES (1) ES462080A1 (da)
FI (1) FI64942C (da)
FR (1) FR2363571A1 (da)
GB (2) GB1590150A (da)
IE (1) IE46152B1 (da)
IL (1) IL52896A (da)
NL (1) NL7709683A (da)
NZ (1) NZ185098A (da)
PT (1) PT67003B (da)
SE (1) SE435839B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013015373A (es) * 2011-06-23 2014-02-11 Map Pharmaceuticals Inc Nuevos analogos de fluoroergolina.

Also Published As

Publication number Publication date
IE46152L (en) 1978-03-06
NZ185098A (en) 1980-04-28
DE2738730A1 (de) 1978-03-16
CA1105007A (en) 1981-07-14
SE435839B (sv) 1984-10-22
FR2363571B1 (da) 1980-04-18
IL52896A (en) 1980-07-31
GB1590150A (en) 1981-05-28
FR2363571A1 (fr) 1978-03-31
FI772557A (fi) 1978-03-07
IL52896A0 (en) 1977-11-30
GB1590149A (en) 1981-05-28
SE7709645L (sv) 1978-03-07
FI64942B (fi) 1983-10-31
DK382777A (da) 1978-03-07
IE46152B1 (en) 1983-03-09
PT67003B (en) 1979-05-14
AU2857277A (en) 1979-03-15
DK147390C (da) 1985-02-04
JPS5331698A (en) 1978-03-25
ES462080A1 (es) 1978-12-01
AU512027B2 (en) 1980-09-18
PT67003A (en) 1977-10-01
NL7709683A (nl) 1978-03-08
DK147390B (da) 1984-07-16

Similar Documents

Publication Publication Date Title
JPH0229080B2 (da)
KR100312539B1 (ko) 피페라진유도체
EP0435749B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
SU1308196A3 (ru) Способ получени 5,11-дигидро-11- @ (1-метил-4-пиперидинил)-амино @ -карбонил @ -6 @ -дибенз ( @ , @ )азепин-6-она или его солей
JPS62283960A (ja) ジ−およびテトラヒドロイソキノリン誘導体およびその製造方法
FI64942C (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar 6'-desoxo-9,10-dihydro-beta-ergocryptin och salter daerav
PT874849E (pt) Derivados octa-hidro-pirrolo¬1,2-a|pirazina 2,7-substituidos
FR2585709A1 (fr) Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4124712A (en) Ergot peptide alkaloid derivatives
FR2643076A1 (fr) Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2652352A1 (fr) Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
JPS5813542B2 (ja) シンキエルゴリンユウドウタイノ セイホウ
US3901891A (en) 13-bromolysergic acid compounds
FI78101C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(2-metoxietyl)-noroximorfoner.
EP0684257B1 (fr) Pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FI68841C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erotpeptidalkaloidderivat
CA2109774A1 (fr) Derives du pyrrole, leur preparation et leur application therapeutique
US4287211A (en) Derivatives of phenylethylamines, processes for their preparation and related pharmaceutical compositions
US3404156A (en) Imidazolin-2-yl-alkyl-substituted indoles
FI71736B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erolinderivat och deras syraadditionssalter
US4547500A (en) Ergot peptide derivatives, their preparation and pharmaceutical compositions containing them
JP3157171B2 (ja) シネルギスチンの製造方法
EP0663903B1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique
EP1476433B1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
CA1192189A (en) E-homo-eburnane derivatives and a process for preparing same

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG